CN104138581A - Traditional Chinese medicine for treating qi-stagnation-in-heart-and-chest syndrome coronary heart disease - Google Patents

Traditional Chinese medicine for treating qi-stagnation-in-heart-and-chest syndrome coronary heart disease Download PDF

Info

Publication number
CN104138581A
CN104138581A CN201310181914.8A CN201310181914A CN104138581A CN 104138581 A CN104138581 A CN 104138581A CN 201310181914 A CN201310181914 A CN 201310181914A CN 104138581 A CN104138581 A CN 104138581A
Authority
CN
China
Prior art keywords
chinese medicine
traditional chinese
stagnation
grams
gram
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310181914.8A
Other languages
Chinese (zh)
Inventor
孙玉建
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201310181914.8A priority Critical patent/CN104138581A/en
Publication of CN104138581A publication Critical patent/CN104138581A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention specifically relates to a traditional Chinese medicine for treating qi-stagnation-in-heart-and-chest syndrome coronary heart disease, which belongs to traditional Chinese medicines. The traditional Chinese medicine is characterized by comprising the following components by weight: 10 to 14 g of unprocessed rehmannia root, 10 to 14 g of red sage root, 10 to 14 g ofcurcuma tuber, 10 to 14 g of Poria cocos, 10 to 14 g of honey-fried licorice root, 10 to 14 g of rosewood and 10 to 14 g of bitter orange. The traditional Chinese medicine is prepared according to the differentiation traditional Chinese medicine theory and has the advantages of simple composition, easy availability of raw materials, low cost, a good curative effect, no toxic and side effects and capacity of effectively treating qi-stagnation-in-heart-and-chest syndrome coronary heart disease.

Description

A kind of Chinese medicine for the treatment of stagnation of QI ambition disease coronary heart disease
Affiliated technical field
The invention belongs to a kind of Chinese medicine, specifically a kind of Chinese medicine for the treatment of stagnation of QI ambition disease coronary heart disease.
Background technology
Stagnation of QI ambition disease coronary heart disease is due to worn with age, healthy energy virtual loss, function damage, yin and yang qi and blood disorder, adds the impact of the factors such as internal injury caused by excess of seven emotions, eating and drinking without temperance, cold stimulation, work and rest mistake degree, causes qi depression to blood stasis, hypofunction of YANG QI in chest, the turbid interior life of expectorant, makes blockage of the cardiac vessels and causes a disease.The symptom of patient's stagnation of QI ambition disease coronary heart disease: cardiac arrhythmia, rapid heart rate, excessively slow, conduction block, asystoles etc. all can make cardiac output lower.Because brain is very responsive to anoxia, blood supply in brain deficiency, it is dizzy that the lighter feels, and dizzyly even fainting can appear in severe one.At present treatment stagnation of QI ambition disease coronary heart disease is generally at present by having Western medicine, and side effect is large, and dependency is strong, causes dose increasing, causes vicious cycle.
Summary of the invention
The present invention's object is exactly the technical deficiency for existing treatment stagnation of QI ambition disease coronary heart disease, and a kind of Chinese medicine for the treatment of stagnation of QI ambition disease coronary heart disease is provided, and has no side effect, and can effectively treat stagnation of QI ambition disease coronary heart disease.
The present invention is by the following technical solutions: the present invention is characterized in that it is made up of the component of following weight portion: Radix Rehmanniae 10-14 gram, Radix Salviae Miltiorrhizae 10-14 gram, Radix Curcumae 10-14 gram, Poria 10-14 gram, Radix Glycyrrhizae Preparata 10-14 gram, Lignum Dalbergiae Odoriferae 10-14 gram, Fructus Aurantii 10-14 gram.
The present invention is preferably made up of the component of following weight portion: 12 grams, the Radix Rehmanniae, 12 grams of Radix Salviae Miltiorrhizaes, 12 grams of Radix Curcumaes, 12 grams, Poria, 12 grams of Radix Glycyrrhizae Preparatas, 12 grams of Lignum Dalbergiae Odoriferaes, 12 grams of Fructus Aurantiis.
One of the selected component of the present invention Radix Rehmanniae, clearing away heat and promoting production of body fluid, removing heat from blood, hemostasis.For consumption of YIN caused by febrile disease, crimson tongue excessive thirst, send out speckle dermexanthesis, spit blood, epistaxis, laryngopharynx swelling and pain.Radix Rehmanniae clearing away heat and cooling blood, yin nourishing, promotes the production of body fluid.For calentura crimson tongue excessive thirst, yin asthenia generating intrinsic heat, hectic fever due to YIN-deficiency consumptive fever, interior-heat is quenched one's thirst, and spits blood, and epistaxis, sends out speckle dermexanthesis.
Radix Salviae Miltiorrhizae, bitter in the mouth, micro-pungent, cold nature; The medicine of the heart, spleen, liver, kidney blood system; There is blood circulation promoting and blood stasis dispelling, nourishing blood to tranquillize the mind, effect of removing heat from blood detumescence; Cure mainly blood stasis head, breast, the side of body, abdomen pain, gather, menoxenia, dysmenorrhea amenorrhea, the stagnant stomachache of the stasis of blood in puerperal, arthralgia, traumatic injury congestive edema, epidemic febrile disease is vexed, palpitation due to deficiency of blood, sore swollen toxin, red rash scabies.
Radix Curcumae, only invigorate blood circulation can; Promoting QI circulation for relieving depression; Removing heat from blood clears away heart-fire; Depressed liver-energy dispersing and function of gallbladder promoting.The all pains of main breast abdomen side of body rib; Dysmenorrhes; Amenorrhea; Lump in the abdomen caking; Calentura coma; Demented; Infantile convulsion; Spit blood; Be defeated in battle standby; Stranguria with blood; Sand Stranguria; Jaundice.
Poria, property slightly sweet flavor is flat, enters the heart, lung, spleen channel.There is eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, effect of mind tranquilizing and the heart calming.Can control dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, malignant histocytosis, has loose bowels, seminal emission, stranguria with turbid discharge, palpitation with fear, forgetful disease such as grade.
Radix Glycyrrhizae Preparata, invigorating the spleen and replenishing QI, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription.For weakness of the spleen and stomach, fatigue and weakness, shortness of breath and palpitation, cough with copious phlegm, gastral cavity abdomen, the anxious pain of extremity contraction, carbuncle sore tumefacting virus, cushion toxicity, strong.
Lignum Dalbergiae Odoriferae, warm in nature, acrid in the mouth.Promoting flow of QI and blood, pain relieving, hemostasis.For epigastric pain, hypochondriac pain due to stagnation of liverQI, thoracic obstruction twinge, injury from falling down, traumatic hemorrhage.
Fructus Aurantii, regulating the flow of QI to ease the stomach, the stagnant relieving distension of row.For the breast side of body stagnation of QI, distension pain, accumulation of food in the stomach and intes tine due to indigestion, stops in phlegm retention; Gastroptosis, proctoptosis, sub-official's prolapsus.
The featured Radix Rehmanniae, Radix Salviae Miltiorrhizae, Radix Curcumae, Poria, Radix Glycyrrhizae Preparata, Lignum Dalbergiae Odoriferae, Fructus Aurantii are decocted with water to 40 minutes.
Using method of the present invention: directly for oral administration with the medicine soup of 1 bowl, every day 2 times, 4-5 days existing positive effects.
The present invention is according to Chinese medical discrimination theory, and prescription is simple, is easy to draw materials, and cost is low, and curative effect is high, has no side effect, and effectively treats stagnation of QI ambition disease coronary heart disease.
Detailed description of the invention
The featured Radix Rehmanniae, Radix Salviae Miltiorrhizae, Radix Curcumae, Poria, Radix Glycyrrhizae Preparata, Lignum Dalbergiae Odoriferae, Fructus Aurantii are decocted with water to 40 minutes.
Apply clinical trial of the present invention:
1. case-data
Patient's case 100 examples, wherein male 50 examples, female's 50 examples, the age is between 20-60 year.
2. Therapeutic Method
Directly for oral administration with the medicine soup of 1 bowl, every day 2 times.
3. curative effect determinate standard
Effective: stagnation of QI ambition disease coronary heart disease symptom is alleviated.
Cure: effectively treat stagnation of QI ambition disease coronary heart disease.
4. result
Patient uses 4-5 days of the present invention, and effective 100 examples are cured 95 examples, cure rate 95%, effective percentage 100%.

Claims (2)

1. treat a Chinese medicine for stagnation of QI ambition disease coronary heart disease, it is characterized in that it is made up of the component of following weight portion: Radix Rehmanniae 10-14 gram, Radix Salviae Miltiorrhizae 10-14 gram, Radix Curcumae 10-14 gram, Poria 10-14 gram, Radix Glycyrrhizae Preparata 10-14 gram, Lignum Dalbergiae Odoriferae 10-14 gram, Fructus Aurantii 10-14 gram.
2. the Chinese medicine of the treatment stagnation of QI according to claim 1 ambition disease coronary heart disease, is characterized in that it is made up of the component of following weight portion: 12 grams, the Radix Rehmanniae, 12 grams of Radix Salviae Miltiorrhizaes, 12 grams of Radix Curcumaes, 12 grams, Poria, 12 grams of Radix Glycyrrhizae Preparatas, 12 grams of Lignum Dalbergiae Odoriferaes, 12 grams of Fructus Aurantiis.
CN201310181914.8A 2013-05-07 2013-05-07 Traditional Chinese medicine for treating qi-stagnation-in-heart-and-chest syndrome coronary heart disease Pending CN104138581A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310181914.8A CN104138581A (en) 2013-05-07 2013-05-07 Traditional Chinese medicine for treating qi-stagnation-in-heart-and-chest syndrome coronary heart disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310181914.8A CN104138581A (en) 2013-05-07 2013-05-07 Traditional Chinese medicine for treating qi-stagnation-in-heart-and-chest syndrome coronary heart disease

Publications (1)

Publication Number Publication Date
CN104138581A true CN104138581A (en) 2014-11-12

Family

ID=51848031

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310181914.8A Pending CN104138581A (en) 2013-05-07 2013-05-07 Traditional Chinese medicine for treating qi-stagnation-in-heart-and-chest syndrome coronary heart disease

Country Status (1)

Country Link
CN (1) CN104138581A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105664038A (en) * 2016-02-26 2016-06-15 济南思拓新源医药科技有限公司 Drug for treating thoracic obstruction type coronary heart disease and preparation method of drug

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105664038A (en) * 2016-02-26 2016-06-15 济南思拓新源医药科技有限公司 Drug for treating thoracic obstruction type coronary heart disease and preparation method of drug

Similar Documents

Publication Publication Date Title
CN103463587B (en) A kind of Chinese medicine composition for the treatment of Deficiency and coldness of spleen and stomach
CN104474471A (en) Traditional Chinese medicine composition for treating thyroid
CN104043057A (en) Traditional Chinese medicinal composition for treating lymph cancer
CN102764315B (en) Medicine for treating goiter
CN102727788B (en) Chinese medicament for treating dampness-heat spleen and stomach type chronic gastritis
CN104138567A (en) Traditional Chinese medicine for treating latent coronary heart disease
CN103394030B (en) Traditional Chinese medicine composition for treating depressed liver and deficient spleen
CN102406765B (en) Traditional Chinese medicine composition for treating acne
CN102626509B (en) Traditional Chinese medicine composite for curing pediatric jaundice
CN103550690B (en) A kind of Chinese medicine composition for the treatment of superficial gastritis
CN104138581A (en) Traditional Chinese medicine for treating qi-stagnation-in-heart-and-chest syndrome coronary heart disease
CN103110811B (en) Traditional Chinese medicine composition for treating arrhythmia
CN102406797B (en) Traditional Chinese medicine composition for treating palpitation
CN104161857A (en) Traditional Chinese medicine for treating heart-kidney yin deficiency symptom-type coronary heart disease
CN104096066A (en) Traditional Chinese medicine for treating heart blood stasis type coronary heart disease
CN104138459A (en) Traditional Chinese medicine for treating qi-and-yin-deficiency coronary heart disease
CN102406879A (en) Chinese medicine composition for treating rhinitis
CN103028105B (en) Traditional Chinese medicine composition for treating headache
CN105079340A (en) Traditional Chinese medicine for treating coronary heart disease with syndromes of qi deficiency and blood stasis
CN104138431A (en) Traditional Chinese medicine for treating angina pectoris type coronary heart disease
CN104096093A (en) Traditional Chinese medicine for treating myocardial infarction type coronary heart disease
CN105267862A (en) Traditional Chinese medicine composition for treating ventricular premature beat
CN105796938A (en) Novel traditional Chinese medicine treatment method of radiation enteritis
CN104147452A (en) Medicine for treating mid-late stage liver cancer
CN105288174A (en) Traditional Chinese medicine for treating ulcerative colitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20141112